Mutations in XIE genes USP9X, NLGN4x, PLXNB3 (involved in axonal guidance and glioma invasion), SYAP1, SRPX2, and ZFX (ZFX-SMARCA1 fusion) occurred in non-MN1-BEND2, predominantly female cases. Here, SMARCA1 is linked to central nervous system cancer.